Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Xia Chen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Maryam Ghasempour | Dentistry | Women Researcher Award

Posted on by Shen Awards

Prof. Dr. Maryam Ghasempour | Dentistry | Women Researcher Award

Babol University of Medical Sciences, Iran

Professor Maryam Ghasempour is a distinguished academic and researcher in pediatric dentistry, with over three decades of experience in clinical practice, teaching, and research. She currently serves as the Head of Postgraduate Studies in the Pediatric Dentistry Department at Babol University of Medical Sciences, where she is also a member of the Research Council and Oral Health Research Center. She has played a key role in advancing pediatric dental research, particularly in the areas of microbiology, dental anomalies, and preventive dentistry. Having published extensively in national and international journals, Professor Ghasempour has contributed significantly to the understanding of oral health in children. Her leadership extends to organizing academic events, including serving as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. She has also mentored numerous postgraduate students, fostering the next generation of dental researchers. Her commitment to evidence-based pediatric dentistry and public health initiatives highlights her influence in the field.

Professional Profile

Education

Professor Maryam Ghasempour’s academic journey began with a Doctorate of Dentistry from Shahid Beheshti Dental School in Tehran, Iran, in 1990. She then specialized in pediatric dentistry, earning a Pedodontics degree from Mashhad Dental School in 1995. Her dedication to furthering her expertise led her to Cardiff University in the United Kingdom, where she completed a fellowship in pediatric dentistry in 2002. This international training enriched her knowledge in advanced techniques and methodologies within pediatric dentistry. Over the years, she has continued her academic progression, achieving the rank of Associate Professor in 2016 and later being promoted to Full Professor at Babol University of Medical Sciences in 2024. Her strong academic background, coupled with extensive research and clinical experience, has established her as a leading expert in pediatric dentistry, with a focus on innovative treatment modalities, oral microbiology, and preventive dental care.

Professional Experience

Professor Ghasempour’s career spans several prestigious roles within the field of pediatric dentistry. She began as an Assistant Professor at Babol University of Medical Sciences in 1995 and has since progressed to Full Professor in 2024. Throughout her career, she has held key administrative and leadership positions, including serving as the Head of Postgraduate Studies in the Pediatric Dentistry Department and as a member of the Research Council at Babol Dental School. She has played an active role in curriculum development, postgraduate mentorship, and interdisciplinary research collaborations. Her influence extends beyond academia, as she has been involved in organizing national and international conferences, including serving as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. Her professional contributions have significantly advanced pediatric dental research and education in Iran and beyond.

Research Interests

Professor Ghasempour’s research focuses on various aspects of pediatric dentistry, including dental microbiology, preventive dentistry, oral health epidemiology, and dental anomalies. She has conducted extensive studies on the role of oral microbiota in early childhood caries, biofilm formation, and the effects of probiotics and natural extracts on dental pathogens. Additionally, she has explored dental developmental anomalies and their clinical implications, as well as the relationship between systemic conditions and oral health. Her research also extends to evaluating new treatment materials, such as fluoride-releasing compounds and antimicrobial agents, for their effectiveness in pediatric dental care. With a strong interest in public health dentistry, she has worked on projects assessing oral health awareness and preventive strategies among children and their families. Her interdisciplinary approach to research has led to numerous high-impact publications in international journals.

Research Skills

Professor Ghasempour possesses a diverse range of research skills that have contributed to her extensive body of work. She is proficient in clinical research methodologies, statistical analysis, and laboratory-based microbiological studies. Her expertise includes in vitro and in vivo experimental designs, molecular microbiology techniques, and biomaterial testing for pediatric dentistry applications. Additionally, she has experience in epidemiological research, conducting large-scale surveys on oral health and dental care practices among pediatric populations. Her ability to integrate clinical practice with scientific inquiry has allowed her to develop innovative approaches for diagnosing and managing pediatric dental conditions. Furthermore, she has strong mentorship skills, guiding postgraduate students in their research endeavors. Her work often involves interdisciplinary collaborations, bridging gaps between dentistry, microbiology, and public health to enhance the understanding and treatment of childhood dental diseases.

Awards and Honors

Throughout her career, Professor Ghasempour has received several awards and recognitions for her contributions to pediatric dentistry and research. Her work has been widely acknowledged in national and international forums, and she has been a recipient of multiple research grants supporting her innovative studies in oral health. As a prominent researcher, she has also been invited to present at numerous academic conferences and serve as a keynote speaker. Her leadership in the field has led to her appointment as the President of the 21st Congress of the Iranian Association of Pediatric Dentistry in 2024. Additionally, her role in advancing dental education and research has been recognized by Babol University of Medical Sciences, where she has played a crucial role in shaping postgraduate programs. These accolades reflect her dedication to improving pediatric dental care through research, education, and public health initiatives.

Conclusion

Professor Maryam Ghasempour is a leading figure in pediatric dentistry, with a distinguished career spanning research, education, and clinical practice. Her extensive publication record, leadership roles, and contributions to dental education have made a lasting impact on the field. She has played a crucial role in advancing pediatric dental research, particularly in microbiology, preventive dentistry, and dental anomalies. Her dedication to mentorship and academic leadership has shaped the next generation of dental professionals. As an advocate for evidence-based dentistry, she continues to contribute to the development of innovative treatment approaches and public health strategies aimed at improving oral health outcomes in children. Through her expertise, research, and leadership, she has established herself as a key figure in pediatric dentistry, making significant strides in both national and international dental communities.

Publications Top Notes

  1. Evaluation of salivary thiobarbituric acid reactive substances, total protein, and pH in children with various degrees of early childhood caries: a case-control study

    • Authors: Aliakbarpour F, Mahjoub S, Masrour-Roudsari J, Seyedmajidi S, Ghasempour M

    • Year: 2021

  2. The association between the salivary cortisol level of mothers, children’s temperament, and early childhood caries

    • Authors: Abedizadeh H, Faramarzi M, Khafri S, Qujeq Q, Ahangary M, Ghasempour M

    • Year: 2021

  3. Anti-Streptococcus mutans property of a chitosan-containing resin sealant

    • Authors: Rajabnia R, Ghasempour M, Gharekhani S, Gholamhoseinnia S, Soroorhomayoon S

    • Year: 2016

  4. Comparative in vitro study of the effectiveness of Green tea extract and common storage media on periodontal ligament fibroblast viability

    • Authors: Adeli F, Zabihi E, Abedian Z, Gharekhani S, Pouramir M, Khafri S, Ghasempour M

    • Year: 2016

  5. Impact of oral and dental health on quality of life in Iranian preschool children and their families

    • Authors: Nemati S, Ghasempour M, Khafri S

    • Year: 2016

  6. Effect of aqueous and ethanolic extracts of Lippia citriodora on Candida albicans

    • Authors: Ghasempour M, Omran SM, Moghadamnia AA, Shafiee F

    • Year: 2016

  7. Relationship between Learning Style and Academic Status of Babol Dental Students

    • Authors: Nasiri Z, Gharekhani S, Ghasempour M

    • Year: 2016

  8. Effect of milk and yogurt on Streptococcus sobrinus counts and caries score in rats

    • Authors: Ghasempour M, Rajabnia R, Ashrafpour M, Ehsani A, Moghadamnia AA, Gharekhani S, Shahandashti EF, Bagheri M

    • Year: 2015

  9. In vitro viability of human periodontal ligament cells in green tea extract

    • Authors: Ghasempour M, Moghadamnia AA, Abedian Z, Amir MP, Feizi F, Gharekhani S

    • Year: 2015

Varun Prabhuji | Conservative Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Varun Prabhuji | Conservative Dentistry | Best Researcher Award

Director at Roots to Cusps Private Limited, India

Dr. Varun Prabhuji is an accomplished dental researcher and clinician with a distinguished academic background and a strong focus on advancing dental science through innovative technology. With multiple patents, trademarks, and research publications, he has made significant contributions to the field of endodontics and minimally invasive dentistry. Dr. Prabhuji’s work emphasizes the development of cutting-edge dental devices and methodologies aimed at improving patient outcomes and clinical efficiency. He is the Director of Roots to Cusps® Private Limited, where he leads efforts in dental innovation, and a Trustee of the Prabhuji Foundation, through which he supports community dental care initiatives. His research has earned him prestigious awards and substantial funding, reflecting his commitment to both academic excellence and practical advancements in dental care. Dr. Prabhuji continues to push the boundaries of dental research while fostering a vision for accessible and high-quality dental solutions.

Professional Profile

Education

Dr. Varun Prabhuji earned his Bachelor of Dental Surgery (BDS) degree from Rajiv Gandhi University of Health Sciences (RGUHS), where he consistently ranked at the top across multiple subjects. During his undergraduate studies, he received several notable accolades, including the IDA Colgate Scholarship and the ISP Merit Award. Currently, he is pursuing a Master of Dental Surgery (MDS) with a focus on advanced endodontic procedures and dental material innovations. His academic journey is marked by a commitment to excellence, with a focus on integrating advanced technology with clinical practice. Throughout his educational career, Dr. Prabhuji has demonstrated an exceptional aptitude for research, leading to the development of patented technologies and innovations. His strong academic foundation, combined with a dedication to continuous learning, positions him as a leader in the dental research community.

Professional Experience

Dr. Varun Prabhuji has amassed substantial experience in both clinical practice and research. As the Director of Roots to Cusps® Private Limited, he spearheads the development of innovative dental products, including patented technologies like PriciGuide® and PriciCrown®. His professional journey includes hands-on clinical work in advanced endodontics and the application of cutting-edge dental materials. In addition to his entrepreneurial role, Dr. Prabhuji actively contributes to the academic community through research publications and conference presentations. He also serves as a Trustee at the Prabhuji Foundation, where he oversees initiatives that provide free dental care to underserved communities. His leadership extends to organizing national and international conferences, fostering dialogue on the latest advancements in dentistry. With a unique blend of clinical expertise and innovative thinking, Dr. Prabhuji continues to drive impactful changes in dental research and patient care.

Research Interests

Dr. Varun Prabhuji’s research interests lie at the intersection of advanced endodontics, dental biomaterials, and minimally invasive dentistry. His work is particularly focused on developing innovative dental devices and techniques that enhance precision and patient outcomes. Dr. Prabhuji is passionate about guided endodontic procedures, a field where he has contributed patented solutions like PriciGuide®. His research extends to exploring novel dental materials and their applications in restorative dentistry, with an emphasis on improving durability and biocompatibility. Another area of interest involves integrating digital technologies into clinical workflows to streamline procedures and enhance diagnostic accuracy. Through his research, Dr. Prabhuji aims to bridge the gap between scientific discovery and practical implementation, ensuring that advancements in dental science translate into tangible benefits for both clinicians and patients. His commitment to innovation is reflected in his ongoing pursuit of new methodologies to improve oral health care.

Research Skills

Dr. Varun Prabhuji possesses a diverse skill set in dental research, encompassing both experimental methodologies and technological innovation. He is proficient in advanced endodontic techniques, including guided endodontics and minimally invasive procedures. His expertise extends to the development and validation of dental biomaterials, where he applies rigorous scientific methodologies to evaluate material performance and biocompatibility. Dr. Prabhuji is also skilled in intellectual property development, with multiple patents and trademarks to his name. He has successfully secured competitive research funding, including grants from IIT Mandi and the Software Technology Park of India (STPI), reflecting his ability to translate research concepts into tangible innovations. Additionally, he is experienced in scholarly writing and has published extensively in peer-reviewed journals. His ability to integrate clinical expertise with research acumen makes him a leading figure in the field of dental innovation and an asset to the broader scientific community.

Awards and Honors

Dr. Varun Prabhuji has received numerous awards recognizing his excellence in dental research and innovation. Among his most notable honors are the IDA Colgate Scholarship and the ISP Merit Award, acknowledging his academic achievements during his undergraduate studies. He is a recipient of the Charaka Award for Excellence in Endodontics and the Young Achiever’s Award, reflecting his contributions to clinical practice and research. Internationally, Dr. Prabhuji was a finalist in the Aesthetic Dentistry MENA Awards 2024 across three categories. His innovative work has also earned him substantial research funding, including a ₹5,00,000 NIDHI PRAYAS grant from IIT Mandi and a ₹1,80,000 grant from STPI. These recognitions underscore his commitment to advancing dental science and his ability to make a significant impact in both academic and clinical domains. Dr. Prabhuji’s accolades highlight his dedication to pushing the boundaries of dental research and improving patient care.

Conclusion

Dr. Varun Prabhuji stands out as a leading figure in dental research and innovation, with a robust academic background and a track record of significant contributions to the field. His expertise spans advanced endodontics, dental biomaterials, and technological innovation, as demonstrated through his patents, research publications, and professional leadership. His ability to merge scientific research with practical applications has led to tangible advancements in dental care. Dr. Prabhuji’s commitment to community service through the Prabhuji Foundation further reflects his dedication to improving oral health beyond the laboratory. With a unique combination of clinical prowess, research innovation, and community impact, he is a deserving candidate for the Excellence in Research Award. His ongoing efforts to advance dental science while maintaining a focus on patient outcomes position him as a transformative force in the field, making a lasting impact on both academic and clinical communities.

Publication Top Notes

  1. Beyond Traditional Techniques: PriciGuide® and PriciPost® Systems – A Glimpse into the Future of Endodontics

    • Authors: Varun Prabhuji, Srirekha A, Veena Pai, Archana S
    • Year: 2025

  2. Saving the Tooth Beneath the Crown: PriciGuide® System for Guided Access Opening Through the Prosthesis

    • Authors: Varun Prabhuji, Srirekha A, Archana S, Suditi Pal
    • Year: 2025

  3. Conquering Calcification: How PriciGuide® System is Transforming Endodontics. A Case Report

    • Authors: Prabhuji Varun, Anand Pari, A Srirekha, Archana S
    • Year: 2025

  4. Comparative Evaluation of Efficacy of Guided Endodontic Technique With and Without Sleeve for Access Cavity Preparation: An In Vitro Study

    • Authors: Varun Prabhuji, S. Archana, A. Srirekha, Veena Pai, C. Champa, Ashwija Shetty
    • Year: 2024

  5. Precision in Endodontic Therapy by Novel-Guided Approach

    • Authors: Md Shabnam, Sujatha Irodi, K.B Jayalakshmi, Varun Prabhuji, Shibani Shetty, Neevika Singh
    • Year: 2024

  6. Calcified Canal Conquered: A Case Report of Minimally Invasive Management of a Calcified Maxillary Central Incisor Using the PriciGuide® System

    • Authors: Ashwija Shetty, Hajira A Sultana, Keerthan B V, Varun Prabhuji
    • Year: 2024

  7. Management of Traumatized Teeth With Severely Calcified Canals and Minimally Invasive Access Cavity Using the AReneto® System: A Case Report

    • Authors: Pucha Sai Manaswini, Varun Prabhuji, Champa C, Srirekha A, Veena S Pai
    • Year: 2024

  8. Digital Precision Meets Dentin Preservation: PriciGuide™ System for Guided Access Opening

    • Authors: Varun Prabhuji, A. Srirekha, Veena Pai, Archana Srinivasan, S. M. Laxmikanth, Shwetha Shanbhag
    • Year: 2024

  9. Device and Method for Dental Treatment Operations

    • Inventor: Varun Prabhuji
    • Year: 2023

  10. Comparative Evaluation of Efficacy of Enzymatic Toothpaste Over Standard Fluoridated Toothpaste in Reduction of Plaque and Gingivitis

    • Authors: Ashwin P S, Varun Prabhuji, Karthikeyan Bangalore Vardhan, Prabhuji MLV
    • Year: 2021

 

 

Qingyuan Zhang | Medical Oncology | Best Researcher Award

Posted on by Shen Awards

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Posted on by Shen Awards

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Posted on by Shen Awards

Assist Prof Dr. Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Professor at Faculty of Dentistry, Mansoura University, Egypt.

Walid A. Al-Zordk is an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry, Mansoura University, Egypt. He holds an MD and a Ph.D. in Fixed Prosthodontics, demonstrating a solid academic foundation and expertise in his field. With extensive teaching experience at several institutions, including Mansoura University and Horus University, he is dedicated to educating the next generation of dental professionals. Dr. Al-Zordk has completed nine research projects, contributing significantly to advancements in prosthodontics, and serves as the Managing Editor of the Mansoura Journal of Dentistry, where he promotes rigorous academic standards. His H-index of 8 reflects his scholarly impact, although there is potential for further growth in publication volume and industry collaboration. Overall, his commitment to research, teaching, and academic leadership positions him as a valuable asset to the dental community and a deserving candidate for the Best Researcher Award.

Profile:

Education

Walid A. Al-Zordk has a strong educational background in the field of dentistry, specifically specializing in Fixed Prosthodontics. He earned his Bachelor of Science in Oral and Dental Medicine from Mansoura University, Egypt. Following this foundational degree, he pursued a Master’s degree in Fixed Prosthodontics at the same institution, further enhancing his expertise in this specialized area. Dr. Al-Zordk continued his academic journey by obtaining a Ph.D. in Fixed Prosthodontics from Mansoura University, solidifying his position as a knowledgeable and skilled practitioner in the field. Throughout his educational experience, he has gained valuable insights and skills, which he has successfully applied in various academic roles, including his current position as an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry. His comprehensive training and dedication to continuous learning underpin his commitment to advancing the field of prosthodontics and educating future dental professionals.

Professional Experience

Walid A. Al-Zordk is an accomplished professional with extensive experience in the field of Fixed Prosthodontics. He began his academic journey as a Clinical Demonstrator in the Department of Conservative Dentistry at Mansoura University, Egypt. His dedication and expertise led him to various roles, including Assistant Lecturer and Lecturer at multiple institutions, such as Delta University for Science and Technology and Horus University. Over the years, he has transitioned to positions of greater responsibility, becoming an Associate Professor at both Mansoura University and Horus University, where he imparts knowledge to aspiring dental professionals. In addition to his teaching roles, Dr. Al-Zordk serves as the Managing Editor of the Mansoura Journal of Dentistry, contributing to the advancement of dental research through editorial oversight. His professional journey reflects a strong commitment to education, research, and the development of innovative practices in the field of dentistry, making him a respected figure in the academic community.

Research Interest

Walid A. Al-Zordk’s research interests primarily focus on the field of prosthodontics, particularly in fixed prosthodontics. He is dedicated to exploring innovative approaches to enhance the quality and longevity of dental restorations, emphasizing the development of advanced materials and techniques that improve patient outcomes. His work investigates the mechanical and biological properties of various dental materials, aiming to understand their interactions within the oral environment. Additionally, Dr. Al-Zordk is keen on integrating digital technologies into prosthodontics, such as computer-aided design and manufacturing (CAD/CAM), to optimize the fabrication of dental prostheses. He also seeks to address challenges in the field, including the management of complex cases and the aesthetics of dental restorations. Through his research, Dr. Al-Zordk aims to contribute to evidence-based practices in dentistry and enhance the educational experience for future dental professionals.

Research Skills

Walid A. Al-Zordk possesses a robust set of research skills that enhance his contributions to the field of Fixed Prosthodontics. His expertise in clinical research methodologies enables him to design and execute studies effectively, ensuring the validity and reliability of his findings. Proficient in data analysis, he utilizes statistical tools to interpret complex datasets, thereby deriving meaningful conclusions that advance dental practices. His strong literature review skills allow him to critically evaluate existing research, identifying gaps and formulating relevant research questions. Furthermore, his experience in managing editorial responsibilities for the Mansoura Journal of Dentistry underscores his understanding of the peer review process and scholarly communication. Dr. Al-Zordk’s ability to collaborate with multidisciplinary teams fosters innovation and knowledge sharing, while his commitment to mentoring emerging researchers ensures the sustainability of academic excellence in prosthodontics. Collectively, these skills position him as a leader in dental research and education.

Award and Recognition

Walid A. Al-Zordk has garnered significant recognition throughout his academic career in the field of Fixed Prosthodontics. He has been acknowledged for his outstanding contributions to dental research, with several accolades highlighting his innovative work. His role as Managing Editor of the Mansoura Journal of Dentistry underscores his influence and dedication to advancing dental education and research. Al-Zordk has presented at various national and international conferences, earning praise for his presentations and fostering collaboration in the dental community. His scholarly contributions, reflected in his H-index of 8, demonstrate the impact of his research on peers and practitioners. Additionally, he is actively involved in mentoring aspiring researchers, further solidifying his reputation as a respected educator. These accomplishments affirm his commitment to excellence and innovation in dentistry, positioning him as a prominent figure in the field and deserving of recognition through prestigious awards.

Conclusion

In conclusion, Walid A. Al-Zordk stands out as a deserving candidate for the Best Researcher Award due to his solid academic foundation, notable research contributions, and leadership in academia. While there are areas for improvement, particularly in increasing his publication and consultancy engagements, his commitment to advancing the field of prosthodontics and his active role in educating future professionals make him a valuable asset to the academic community. His recognition through this award would not only honor his achievements but also inspire continued excellence in dental research and education.

Publication Top Notes

  • Computer vision based distributed denial of service attack detection for resource-limited devices
    • Authors: Gebrye, H., Wang, Y., Li, F.
    • Year: 2024
    • Journal: Computers and Electrical Engineering
    • Volume/Issue/Page: 120, 109716
  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: El-Gizawy, S.A., Osman, M.A., Arafa, M.F., El Maghraby, G.M.
    • Year: 2015
    • Journal: International Journal of Pharmaceutics
    • Volume/Issue/Page: 478(2), 773-778
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2016
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 42(8), 1225-1233
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: Eid, R.K., Ashour, D.S., Essa, E.A., El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 232, 115826
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2018
    • Journal: Pharmaceutical Development and Technology
    • Volume/Issue/Page: 23(5), 454-463
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2017
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 38, 9-17
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: El Maghraby, G.M., Arafa, M.F., Osman, M.A.
    • Year: 2014
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 40(12), 1637-1644
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: Marei, H.F., Arafa, M.F., Essa, E.A., El Maghraby, G.M.
    • Year: 2021
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 61, 102338
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: Elmehy, D.A., Saad, M.A.H., El Maghraby, G.M., Arafa, M.F., Soliman, N.A., …
    • Year: 2021
    • Journal: Parasitology Research
    • Volume/Issue/Page: 120(7), 2641-2658
  • Liposomes for enhanced cellular uptake of anticancer agents
    • Authors: El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Current Drug Delivery
    • Volume/Issue/Page: 17(10), 861-873

 

 

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11